Silvia Mezi

Summary

Affiliation: University of Rome La Sapienza
Country: Italy

Publications

  1. ncbi In vivo detection of resistance to anthracycline based neoadjuvant chemotherapy in locally advanced and inflammatory breast cancer with technetium-99m sestamibi scintimammography
    Silvia Mezi
    Dipartimento di Medicina Sperimentale e Patologia, Policlinico Umberto I, I 00161 Rome, Italy
    Int J Oncol 22:1233-40. 2003
  2. pmc Neuroendocrine tumors of the gallbladder: a case report and review of the literature
    Silvia Mezi
    Department of Radiology, Oncology and Human Pathology, Division of Oncology B, Sapienza University of Rome, Rome, Italy
    J Med Case Reports 5:334. 2011
  3. ncbi Somatostatin receptor scintigraphy in metastatic breast cancer patients
    Silvia Mezi
    Department of Experimental Medicine and Pathology, S S of Oncology, University of Rome La Sapienza, I 00161 Rome, Italy
    Oncol Rep 13:31-5. 2005
  4. ncbi Incidence and relative risk of hepatic toxicity in patients treated with anti-angiogenic tyrosine kinase inhibitors for malignancy
    Roberto Iacovelli
    Department of Radiology, Oncology and Human Pathology, Sapienza University of Rome, Oncology Unit B, Viale Regina Elena 324, 00161, Rome, Italy
    Br J Clin Pharmacol 77:929-38. 2014
  5. doi Involvement of the Src-cortactin pathway in migration induced by IGF-1 and EGF in human breast cancer cells
    Silvia Mezi
    Department of Radiology, Oncology and Human Pathology, Division of Oncology B, Sapienza University of Rome, Rome, Italy
    Int J Oncol 41:2128-38. 2012
  6. doi Incidence and risk of pulmonary toxicity in patients treated with mTOR inhibitors for malignancy. A meta-analysis of published trials
    Roberto Iacovelli
    Dipartimento di Scienze Radiologiche, Oncologiche e Anatomo Patologiche, Sapienza Universita di Roma, Rome, Italy
    Acta Oncol 51:873-9. 2012
  7. ncbi Tolerability of Raltitrexed ('Tomudex') in elderly patients with colorectal cancer
    Adriana Romiti
    National Cancer Institute of Genoa, Section of Rome, Department of Experimental Medicine and Pathology, La Sapienza University of Rome, Rome, Italy
    Anticancer Res 22:3071-6. 2002

Collaborators

Detail Information

Publications7

  1. ncbi In vivo detection of resistance to anthracycline based neoadjuvant chemotherapy in locally advanced and inflammatory breast cancer with technetium-99m sestamibi scintimammography
    Silvia Mezi
    Dipartimento di Medicina Sperimentale e Patologia, Policlinico Umberto I, I 00161 Rome, Italy
    Int J Oncol 22:1233-40. 2003
    ..The scintigraphy protocol, including 2 studies before and after NACT, is useful for detecting intrinsic and acquired chemoresistant BC in vivo, which is important for planning therapy and predicting prognosis...
  2. pmc Neuroendocrine tumors of the gallbladder: a case report and review of the literature
    Silvia Mezi
    Department of Radiology, Oncology and Human Pathology, Division of Oncology B, Sapienza University of Rome, Rome, Italy
    J Med Case Reports 5:334. 2011
    ..abstract:..
  3. ncbi Somatostatin receptor scintigraphy in metastatic breast cancer patients
    Silvia Mezi
    Department of Experimental Medicine and Pathology, S S of Oncology, University of Rome La Sapienza, I 00161 Rome, Italy
    Oncol Rep 13:31-5. 2005
    ..If our results are confirmed in large scale studies, SRS shows the potential to treat selected patients with overexpressed SS-R on their tumoral cells with designed target therapies with SS analogue...
  4. ncbi Incidence and relative risk of hepatic toxicity in patients treated with anti-angiogenic tyrosine kinase inhibitors for malignancy
    Roberto Iacovelli
    Department of Radiology, Oncology and Human Pathology, Sapienza University of Rome, Oncology Unit B, Viale Regina Elena 324, 00161, Rome, Italy
    Br J Clin Pharmacol 77:929-38. 2014
    ..The aim of this study is to investigate the incidence and risk of hepatic toxicity in patients receiving tyrosine kinase inhibitors (TKIs) through a large up-to-date meta-analysis of available clinical trials...
  5. doi Involvement of the Src-cortactin pathway in migration induced by IGF-1 and EGF in human breast cancer cells
    Silvia Mezi
    Department of Radiology, Oncology and Human Pathology, Division of Oncology B, Sapienza University of Rome, Rome, Italy
    Int J Oncol 41:2128-38. 2012
    ....
  6. doi Incidence and risk of pulmonary toxicity in patients treated with mTOR inhibitors for malignancy. A meta-analysis of published trials
    Roberto Iacovelli
    Dipartimento di Scienze Radiologiche, Oncologiche e Anatomo Patologiche, Sapienza Universita di Roma, Rome, Italy
    Acta Oncol 51:873-9. 2012
    ..Since their approval, several cases of pulmonary toxicity (PT) have been described. This analysis aims to report the incidence and the risk of PT in published randomized controlled trials...
  7. ncbi Tolerability of Raltitrexed ('Tomudex') in elderly patients with colorectal cancer
    Adriana Romiti
    National Cancer Institute of Genoa, Section of Rome, Department of Experimental Medicine and Pathology, La Sapienza University of Rome, Rome, Italy
    Anticancer Res 22:3071-6. 2002
    ..In this retrospective study, the tolerability of raltitrexed in patients with CRC was examined in relation to age...